Detalhe da pesquisa
1.
Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy.
Transpl Int
; 35: 10228, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35497889
2.
Treatment impact on COVID-19 evolution in hemodialysis patients.
Kidney Int
; 98(4): 1053-1054, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750459
3.
Long-term impact of COVID-19 among maintenance haemodialysis patients.
Clin Kidney J
; 15(2): 262-268, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35140935
4.
Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients.
Clin Kidney J
; 14(8): 1908-1914, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34345414